VSCI Stock Quote and Technical Analysis
| Portfolios | Markets | Resources |
|
|
|
Vision-Sciences, Inc. (VSCI) ▼ 0.97 (-0.02) -2.02% Open: 0.9629 High: 1.08 Low: 0.96 Afterhours: N/A - N/A Volume: 17055 6/18/2013 3:59pm |
Interactive Chart |
| EPS: -0.23 (Current Year Estimated: -0.21) Dividend: N/A P/E: N/A Technicals: 52 Week Range: 0.89 - 1.70 50 Day Moving Average: 1.0289 200 Day Moving Average: 1.07 Pivot Point (Next Trading Session): 1 Login or signup free to Add "VSCI" to your portfolio Resources: |
| News: VISION SCIENCES INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Princ Tue, 18 Jun 2013 14:31:02 GMT VISION SCIENCES INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers Thu, 16 May 2013 14:25:07 GMT VISION SCIENCES INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Princ Wed, 15 May 2013 03:08:33 GMT Vision Sciences appoints Howard Zauberman as interim CEO Mon, 13 May 2013 21:10:52 GMT Vision-Sciences Appoints Howard Zauberman as Interim Chief Executive Officer Mon, 13 May 2013 21:01:49 GMT [GlobeNewswire] - ORANGEBURG, N.Y. -- Vision-Sciences, Inc. , a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath(R) technology, today announced that Howard ... Vision-Sciences' CEO Discusses F4Q2013 Results - Earnings Call Transcript Tue, 30 Apr 2013 14:19:04 GMT [at Seeking Alpha] - Vision-Sciences' CEO Discusses F4Q2013 Results - Earnings Call Transcript VISION SCIENCES INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Tue, 30 Apr 2013 03:20:57 GMT Vision-Sciences Announces Revenue of $4.2 Million for Fourth Quarter and $15.3 Million for Full Year Fiscal 2013 Mon, 29 Apr 2013 22:10:06 GMT [at noodls] - April 29, 2013 Vision-Sciences Announces Revenue of $4.2 Million for Fourth Quarter and $15.3 Million for Full Year Fiscal 2013 ORANGEBURG, N.Y., April 29, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. ... Vision-Sciences Announces Revenue of $4.2 Million for Fourth Quarter and $15.3 Million for Full Year Fiscal 2013 Mon, 29 Apr 2013 21:30:00 GMT [GlobeNewswire] - ORANGEBURG, N.Y. -- Vision-Sciences, Inc. , a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath(R) technology, today announced financial results ... Q4 2013 Vision Sciences Inc Earnings Release - After Market Close Mon, 29 Apr 2013 11:07:06 GMT Vision-Sciences Announces Release Date of Fourth Quarter and Full Year Fiscal 2013 Results Tue, 23 Apr 2013 22:06:07 GMT [at noodls] - April 23, 2013 Vision-Sciences Announces Release Date of Fourth Quarter and Full Year Fiscal 2013 Results ORANGEBURG, N.Y., April 23, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading ... Vision-Sciences Announces Release Date of Fourth Quarter and Full Year Fiscal 2013 Results Tue, 23 Apr 2013 21:18:56 GMT [GlobeNewswire] - ORANGEBURG, N.Y. -- Vision-Sciences, Inc. , a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath(R) technology, today announced that the Company ... Vision-Sciences Announces Launch of Next-Generation Video Endoscopy System Tue, 19 Mar 2013 16:09:38 GMT [at noodls] - March 18, 2013 The 7000 Series Vision System(R) Offers Imaging, Video/Audio Archiving, and Workflow Features in One Platform ORANGEBURG, N.Y., March 18, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), ... Vision-Sciences Announces Launch of Next-Generation Video Endoscopy System Mon, 18 Mar 2013 20:05:00 GMT [GlobeNewswire] - ORANGEBURG, N.Y. -- Vision-Sciences, Inc. , a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath(R) technology, today announced the launch of ... Vision-Sciences Appoints Cheryl Pegus, MD, MPH to Board of Directors Wed, 13 Mar 2013 14:55:49 GMT [at noodls] - March 12, 2013 ORANGEBURG, N.Y., March 12, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable ... VISION SCIENCES INC /DE/ Files SEC form 8-K, Financial Statements and Exhibits Wed, 13 Mar 2013 12:49:51 GMT Vision-Sciences to Present at Canaccord Genuity Musculoskeletal Conference Wed, 06 Mar 2013 21:58:05 GMT [at noodls] - March 6, 2013 ORANGEBURG, N.Y., March 6, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable ... Vision-Sciences to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference Thu, 07 Feb 2013 20:22:13 GMT [at noodls] - February 7, 2013 Vision-Sciences to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference ORANGEBURG, N.Y., Feb. 7, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), ... VISION SCIENCES INC /DE/ Financials Fri, 01 Feb 2013 18:04:24 GMT VISION SCIENCES INC /DE/ Files SEC form 10-Q, Quarterly Report Tue, 29 Jan 2013 15:35:42 GMT All Company News is Powered by Yahoo! Finance |
All Discover Card holders who did NOT call in and switch to the new Discover IT Card. You may be receiving less than you should be on your cash back. According to the folks working the Discover IT...
Discover